Reported high-risk factors of linezolid-induced thrombocytopenia and reduction in the hemoglobin level include low platelet count, low body weight, low level of albumin, old age, longer duration of medication, renal insufficiency, and Cmin >8 mg/L (Chen et al., 2012; Lin et al., 2022). The gene discussed is ALB; the disease is Thrombocytopenia.